Blog - Page 3773 of 5745

TuesdaySep 07, 2010 1:07 pm

NeoStem (NBS) Appoints Seasoned President and Managing Director

NeoStem Inc. develops stem cell-based therapies and has built a network of adult stem cell collection centers in the U.S. and China. The company today announced Ian Zhang, Ph.D., MBA, as its new president and managing director. Dr. Zhang holds an MBA from the University of Chicago, Graduate School of Business and holds a Ph.D. in biotechnology from Simon Fraser University. He continued his education as a postdoctoral fellow at Yale University School of Medicine. Dr. Zhang is focused on growth strategy and acquisitions/integrations in the biotech field, with a primary dedication to biotech growth in Asia. He has extensive…

TuesdaySep 07, 2010 12:21 pm

Micro Identification Technologies, Inc. (MMTC.OB) Offers Best Solution to Major Problem

If ever there was a company that has lived up to the old business adage “Find a good solution to an important problem”, it is California based Micro Identification Technologies Inc. There’s little question about the importance of the issue they are addressing, the growing need for quicker and easier identification of potentially deadly bacteria. The increasing globalization and industrialization of the world’s food supply has made the potential for contamination a threat that can affect food consumers everywhere. • Microbial contamination, in hospitals and food products, has grown in recent years. • Accurate identification of contamination typically takes at…

TuesdaySep 07, 2010 11:30 am

China Direct Industries, Inc. (CDII) Video Chart for Tuesday, September 7, 2010

CDII is forming a base at $.94 and appears to be trying to make a move north. While the indicators have given a “head-fake” in the past, they are aligned again for a possible move. Please click the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

TuesdaySep 07, 2010 10:21 am

Rexahn Pharmaceuticals (RNN) Submits Phase IIb Protocol to FDA for Major Depressive Disorder Treatment

Rexahn Pharmaceuticals Inc., a clinical stage company focused on developing and commercializing oncology and CNS therapeutics, has submitted a phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin to assess the drug’s efficacy as treatment for major depressive disorder (MDD). The double blind, randomized, placebo-controlled trial will involve approximately 300 subjects, and will be conducted at multiple sites in the U.S. The study will measure the change from the baseline, with the Montgomery-Asberg Depression Rating Scale (MADRS) as the primary efficacy endpoint. In Rexahn's phase IIa proof of concept study, Serdaxin demonstrated…

TuesdaySep 07, 2010 10:20 am

Elecsys Corp. (ESYS) Reports Second Fiscal Quarter Results

Elecsys Corporation reported a large increase in revenue on a year over year basis in the second quarter of fiscal 2010, which ended 7/31/2010. The company attributed the increase to strong demand for both its existing and newly introduced products. Elecsys Corporation reported revenue of $5.2 million in the second quarter of fiscal 2010, compared to revenue of $3.6 million in the second quarter of fiscal 2009. Elecsys Corporation also improved its net income in the most recent quarter compared to the same quarter in fiscal 2009. Elecsys Corporation reported net income of $0.01 million, or $0.03 per diluted share,…

TuesdaySep 07, 2010 10:18 am

China North East Petroleum Holdings Ltd. (NEP) Reports Higher Second Quarter 2010 Sales

China North East Petroleum Holdings Ltd. reported a large increase in sales, and a strong profit in the second quarter of 2010. The improved results were due to a large increase in realized oil prices during the quarter. China North East Petroleum Holdings Ltd. had sales of $27.2 million in the second quarter of 2010, compared to $11.4 million in the same quarter of 2009. However, China North East Petroleum Holdings Ltd. reported an eleven percent decline in oil production from the company’s wells during the quarter. The company reported production of 198,776 barrels of oil, compared to production of…

TuesdaySep 07, 2010 9:59 am

Balqon Corp. (BLQN.OB) Signs Dealer Agreement with Beltway International

Balqon Corporation is a developer and manufacturer of zero-emissions, heavy-duty electric vehicle and drive systems. The company announced today that it has entered into a dealer agreement with Beltway International LLC, Maryland's largest full-service domestic and international truck dealer. Under the terms of the agreement, Beltway International has agreed to distribute Balqon's Nautilus XE20, a zero-emissions electric tractor powered by lithium-ion batteries, and Balqon's proprietary drive system technology. The Nautilus XE20 can tow up to 30 tons of cargo at speeds of up to 25 miles per hour. The tractor is designed for “in-terminal” operations to transport containers at facilities…

TuesdaySep 07, 2010 9:57 am

Revolutions Medical Corp. (RMCP.OB) Secures Major Agreement

Revolutions Medical Corporation is a company that investors are starting to take notice of. Located in Charleston, South Carolina, Revolutions Medical Corp. (RevMed) is an up-and-comer in the medical sector. Today, RevMed took a major step towards prominence with the announcement they have secured a binding 5 year agreement for the manufacture of the RevVac 3mi Auto-retractable safety syringe with the Medical Investment Group (MIG). Final documents of this agreement will be signed on or before September 17, 2010 with more specifics to come at the final signing. This agreement with MIG will fulfill this obligation through its relationship with…

TuesdaySep 07, 2010 7:57 am

Consorteum Holdings, Inc. (CSRH.OB) Completes First Stage of Testing Currency Conversion and Payment Initiative

Consorteum Holdings, Inc. this morning updated the investment community regarding the pilot program for the Company's first international payroll and multi-currency solution with UK based Blue Sea Manning Ltd. ("BSM"). The Company officially launched the solution in March 2010. Consorteum and BSM successfully completed the first stage of testing for deposits and currency conversions. The companies are now commencing stage two of this initiative, which includes introducing the program to BSM's remaining employees to ensure that the program continues to perform properly. The completion of this phase will enable larger scale deployment in the coming months. Craig Fielding, CEO of…

TuesdaySep 07, 2010 7:31 am

MedLink (MLKNA.OB) Secures Partnership with Thrasys, Inc., a Healthcare Information Technology Provider

MedLink, a healthcare IT company that provides the medical community with products and services designed to help create, manage, and share medical information, recently announced that the company has secured a partnership with Thrasys, Inc., a provider of next-generation health information technology and solutions. MedLink and Thrasys will market the cloud-based HIE platform to Regional Health Information Organizations (RHIOs) and large hospital groups as a solution for interoperability, and to provide cloud-based applications that leverage both technologies. MedLink and Thrasys have collaborated to provide interoperability and health record management based on SyntraNet from Thrasys, a cloudbased Health Information Exchange (HIE)…

Site Search

Company Search